Therefore, we sought to stratify the prognosis of these patients due to a few factors that impact the choice of therapy and outcome of hepatocellular carcinoma patients: liver stiffness, hepatic venous pressure gradient, tumor burden score, serum AFP (alpha-fetoprotein) and Child–Pugh (CP) classification. The gene discussed is AFP; the disease is neoplasm.